$XGN
EXAGEN INC. Stock $xgn

$xgn Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000127473723000088 Filed on August 07, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$13.42M	$14.14M
YoY Change	-8.9%	57.74%
Cost Of Revenue	$5.710M	$5.836M
YoY Change	-4.99%	-3.98%
Gross Profit	$7.706M	$8.301M
YoY Change	-11.59%	187.83%
Gross Profit Margin	57.44%	58.72%
Selling, General & Admin	$11.38M	$11.95M
YoY Change	-19.62%	-7.36%
% of Gross Profit	147.61%	143.99%
Research & Development	$1.400M	$1.263M
YoY Change	-41.23%	-53.03%
% of Gross Profit	18.17%	15.22%
Depreciation & Amortization	$600.0K	$500.0K
YoY Change	50.0%	66.67%
% of Gross Profit	7.79%	6.02%
Operating Expenses	$12.78M	$13.22M
YoY Change	-22.73%	-15.24%
Operating Profit	-$5.069M	-$4.915M
YoY Change	-35.15%	-61.32%
Interest Expense	$557.0K	$574.0K
YoY Change	-190.13%	-5.28%
% of Operating Profit
Other Income/Expense, Net	$211.0K	$476.0K
YoY Change	-37.76%	9420.0%
Pretax Income	-$5.415M	-$5.013M
YoY Change	-33.12%	-62.33%
Income Tax
% Of Pretax Income
Net Earnings	-$5.415M	-$5.013M
YoY Change	-33.12%	-62.33%
Net Earnings / Revenue	-40.36%	-35.46%
Basic Earnings Per Share	-$0.31	-$0.28
Diluted Earnings Per Share	-$0.31	-$0.28
COMMON SHARES
Basic Shares Outstanding	16.86M shares	16.83M shares
Diluted Shares Outstanding	17.69M shares	17.66M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.45M	$31.47M
YoY Change	-58.59%	-58.81%
Cash & Equivalents	$28.45M	$31.47M
Short-Term Investments
Other Short-Term Assets	$2.239M	$1.653M
YoY Change	-17.59%	53.48%
Inventory
Prepaid Expenses
Receivables	$17.04M	$16.24M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$48.91M	$51.27M
YoY Change	-40.4%	-42.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.38M	$12.29M
YoY Change	-15.34%	-2.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$638.0K	$620.0K
YoY Change	8.87%	-0.8%
Total Long-Term Assets	$12.02M	$12.91M
YoY Change	-38.48%	-30.92%
TOTAL ASSETS
Total Short-Term Assets	$48.91M	$51.27M
Total Long-Term Assets	$12.02M	$12.91M
Total Assets	$60.93M	$64.18M
YoY Change	-40.03%	-40.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.657M	$1.309M
YoY Change	-54.84%	-57.84%
Accrued Expenses	$7.063M	$5.933M
YoY Change	-7.83%	8.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$261.0K	$257.0K
YoY Change	-64.25%	-62.15%
Total Short-Term Liabilities	$10.12M	$8.603M
YoY Change	-10.7%	-10.13%
LONG-TERM LIABILITIES
Long-Term Debt	$19.19M	$19.15M
YoY Change	-31.47%	-31.17%
Other Long-Term Liabilities	$484.0K	$597.0K
YoY Change	-91.6%	-26.3%
Total Long-Term Liabilities	$19.68M	$19.75M
YoY Change	-41.74%	-31.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.12M	$8.603M
Total Long-Term Liabilities	$19.68M	$19.75M
Total Liabilities	$33.42M	$32.28M
YoY Change	-26.4%	-25.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$273.6M	-$268.2M
YoY Change	13.43%	15.75%
Common Stock	$17.00K	$17.00K
YoY Change	6.25%	6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.50M	$31.90M
YoY Change
Total Liabilities & Shareholders Equity	$60.93M	$64.18M
YoY Change	-40.03%	-40.42%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$5.415M	-$5.013M
YoY Change	-33.12%	-62.33%
Depreciation, Depletion And Amortization	$600.0K	$500.0K
YoY Change	50.0%	66.67%
Cash From Operating Activities	-$2.911M	-$10.15M
YoY Change	-56.44%	-8.97%
INVESTING ACTIVITIES
Capital Expenditures	$2.000K	$324.0K
YoY Change	-100.23%	-116.65%
Acquisitions
YoY Change
Other Investing Activities	$2.000K	$2.000K
YoY Change
Cash From Investing Activities	$0.00	-$322.0K
YoY Change	-100.0%	-83.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-112.0K	-10.24M
YoY Change	409.09%	3779.55%
NET CHANGE
Cash From Operating Activities	-2.911M	-10.15M
Cash From Investing Activities	0.000	-322.0K
Cash From Financing Activities	-112.0K	-10.24M
Net Change In Cash	-3.023M	-20.72M
YoY Change	-60.13%	55.03%
FREE CASH FLOW
Cash From Operating Activities	-$2.911M	-$10.15M
Capital Expenditures	$2.000K	$324.0K
Free Cash Flow	-$2.913M	-$10.48M
YoY Change	-49.8%	13.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	84936000	usd
CY2022Q1	exdx	Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes Value IssuanceOfStockFromVestedRestrictedStockUnitsAndPaymentOfEmployeesTaxesValue	115000	usd
CY2022Q2	exdx	Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes Value IssuanceOfStockFromVestedRestrictedStockUnitsAndPaymentOfEmployeesTaxesValue	107000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1440000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-14665000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	62824000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12701000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24937000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	1056000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	597000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	80000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	78000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	226000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	272000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-129000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	exdx	Non Cash Lease Expense NonCashLeaseExpense	473000	usd
	exdx	Non Cash Lease Expense NonCashLeaseExpense	514000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1964000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2816000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10158000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-939000	usd
	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-573000	usd
	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-576000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	101000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	201000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-506000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-382000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1750000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	751000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	812000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-751000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19903000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19728000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	720000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3033000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-718000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3033000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	222000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	152000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	231000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	369000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	303000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	114000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10304000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-294000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30925000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23055000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62591000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99542000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31666000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76487000	usd
	us-gaap	Interest Paid Net InterestPaidNet	898000	usd
	us-gaap	Interest Paid Net InterestPaidNet	860000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	293000	usd
	exdx	Equipment Purchased Under Notes Payable Obligations EquipmentPurchasedUnderNotesPayableObligations	250000	usd
	exdx	Equipment Purchased Under Notes Payable Obligations EquipmentPurchasedUnderNotesPayableObligations	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	61000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	391000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31500000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-268200000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risk and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents and accounts receivable. Substantially all the Company's cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its cash or cash equivalents.</span></div>
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14137000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7606000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25367000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31466000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62391000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31666000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62591000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1500000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1200000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1800000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1600000	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	400000	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	600000	usd
	us-gaap	Advertising Expense AdvertisingExpense	700000	usd
	us-gaap	Advertising Expense AdvertisingExpense	900000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3062931	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3173725	shares
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1100000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	600000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1653000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1795000	usd
CY2023Q2	us-gaap	Prepaid Royalties PrepaidRoyalties	39000	usd
CY2022Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	40000	usd
CY2023Q2	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	1860000	usd
CY2022Q4	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	2072000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	18000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	236000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3570000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4143000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	14038000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	13321000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6163000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5124000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7875000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8197000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3284000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2355000	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	130000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	142000	usd
CY2023Q2	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	435000	usd
CY2022Q4	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	803000	usd
CY2023Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	62000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	514000	usd
CY2023Q2	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	121000	usd
CY2022Q4	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	162000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	595000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	700000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	700000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	usd
CY2023Q2	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	254000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	445000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	352000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	226000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5933000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5347000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	950000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1908000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1928000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	21215000	usd
CY2023Q2	exdx	Long Term Debt Including Undiscounted Interest LongTermDebtIncludingUndiscountedInterest	26001000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	134000	usd
CY2023Q2	exdx	Long Term Debt Undiscounted Interest Amount LongTermDebtUndiscountedInterestAmount	6457000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	19410000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	257000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19153000	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	6900000	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	8000000.0	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	9200000	usd
	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	700000	usd
CY2023Q2	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	700000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1214059	shares
	exdx	Stock Issued During Period Shares Warrants Exercised Net StockIssuedDuringPeriodSharesWarrantsExercisedNet	0	shares
CY2023Q2	exdx	Stock Issued During Period Shares Warrants Exercised Net StockIssuedDuringPeriodSharesWarrantsExercisedNet	0	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	200000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1440000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1964000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2816000	usd

Files In Submission

Name	View Source	Status
0001274737-23-000088-index-headers.html	Edgar Link	pending
0001274737-23-000088-index.html	Edgar Link	pending
0001274737-23-000088.txt	Edgar Link	pending
0001274737-23-000088-xbrl.zip	Edgar Link	pending
exdx-20230630.htm	Edgar Link	pending
exdx-20230630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
exdx-20230630_cal.xml	Edgar Link	unprocessable
exdx-20230630_def.xml	Edgar Link	unprocessable
exdx-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
exdx-20230630_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xgn311-063023.htm	Edgar Link	pending
xgn312-063023.htm	Edgar Link	pending
xgn321-063023.htm	Edgar Link	pending
exdx-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XGN
EXAGEN INC. Stock $xgn

2023 Q3 Form 10-Q Financial Statement

#000127473723000088 Filed on August 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN EXAGEN INC. Stock $xgn

2023 Q3 Form 10-Q Financial Statement

#000127473723000088 Filed on August 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN
EXAGEN INC. Stock $xgn